Sanders Morris Harris’s MacroGenics MGNX Stock Holding History

Sanders Morris Harris’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-12,345	Closed	-$35.7K	–	198
2026 Q1	$35.7K	Buy	+12,345	New	+$26.3K	0.01%	289
2025 Q4	–	Sell	-12,345	Closed	-$20.7K	–	195
2025 Q3	$20.7K	Buy	+12,345	New	+$20K	﹤0.01%	302
2025 Q2	–	Sell	-12,345	Closed	-$15.1K	–	244
2025 Q1	$15.1K	Hold	12,345	–	–	﹤0.01%	281
2024 Q4	$40.1K	Buy	+12,345	New	+$44.5K	0.01%	280
2022 Q4	–	Sell	-18,345	Closed	-$64K	–	242
2022 Q3	$64K	Hold	18,345	–	–	0.02%	280
2022 Q2	$56K	Hold	18,345	–	–	0.01%	279
2022 Q1	$162K	Hold	18,345	–	–	0.03%	278
2021 Q4	$310K	Hold	18,345	–	–	0.05%	232
2021 Q3	$377K	Hold	18,345	–	–	0.07%	208
2021 Q2	$522K	Sell	18,345 -2,570	-12%	-$75.3K	0.1%	163
2021 Q1	$659K	Hold	20,915	–	–	0.14%	119
2020 Q4	$426K	Hold	20,915	–	–	0.1%	176
2020 Q3	$540K	Buy	+20,915	New	+$571K	0.15%	129
2020 Q2	–	Sell	-23,845	Closed	-$125K	–	160
2020 Q1	$125K	Buy	+23,845	New	+$217K	0.12%	111

Other funds holding MGNX

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Sanders Morris Harris's MGNX Position: Q2 2026 in Review

Sanders Morris Harris sold out of MacroGenics (MGNX) in Q2 2026, closing a stake of 12,345 shares — an estimated $35.7K sold.

Sanders Morris Harris first reported a position in MGNX in Q1 2020 and held it in 14 quarters. The position peaked at $659K in Q1 2021. 122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

Sanders Morris Harris reported no remaining MacroGenics position as of Q2 2026 after selling out during the quarter.
Sanders Morris Harris sold 12,345 MacroGenics shares in Q2 2026, an estimated $35.7K.
Sanders Morris Harris first reported a position in MacroGenics in Q1 2020 and held it in 14 quarters.
Sanders Morris Harris's MacroGenics position peaked at $659K in Q1 2021.
122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on Sanders Morris Harris's 13F filing for Q2 2026, filed 7 Jul 2026.